Neuro Kinetics Statement Concerning Newspap... ( PITTSBURGH Nov. 10 /- Neuro Kinetics ...)

Neuro Kinetics Statement Concerning Newspaper Article

Date:11/10/2009

PITTSBURGH, Nov. 10 /PRNewswire/ -- Neuro Kinetics, Inc. (www.neuro-kinetics.com) , manufacturers of noninvasive medical evaluation equipment used worldwide to test for vestibular and neurological dysfunctions, today issued the following statement from CEO J. Howison Schroeder related to an article published Friday, November 6, 2009, by the Pittsburgh Tribune Review:

"We are concerned about wrong impressions readers of the Tribune's article might draw, particularly current and prospective users of our equipment in hospitals, universities, clinical offices, military medical facilities, government agencies and elsewhere who might call up the story online or see it linked from an online research service.

"The Tribune article stated that there are lingering regulatory issues and that we had been 'forced to recall' 72 devices. In fact, there are no lingering regulatory issues and no Neuro Kinetics physical equipment has ever been recalled for any reason whatsoever, anywhere in the world. We did recently undertake a voluntary initiative, with guidance and approval from the U.S. Food and Drug Administration (FDA), to distribute an updated version of our software (known as VEST(TM)) that we provide our users to operate our testing equipment and to generate analysis of patient evaluations. As our customers know, this updated version of VEST removed only a small portion of the software -- normative data pertaining to certain tests that can be conducted on some of our equipment.

"The so-called 'recall' was of a small slice of software-stored data, not the overall software program and certainly not any of our physical equipment. We feel it is important that our current and prospective users understand that distinction.

"All medical equipment manufacturers have a responsibility to meet the highest standards of safe, efficient and effective patient care. At Neuro Kinetics,
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine technology :

1. NeurogesX Expands Commercial Operations Leadership Team
2. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
3. Neuronascent Announces Collaboration with ChemRar for Characterization of Developmental Pathway Inhibitors Using Neuronascents Neurogenesis Platform
4. NeurogesX to Hold Conference Call to Discuss Third Quarter 2009 Financial Results
5. Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology
6. Neuro Kinetics & Military Researchers in Push To Improve Diagnosis & Treatment of Combat Brain Injuries
7. Neurocrine Biosciences Reports Third Quarter 2009 Results
8. Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
10. Child Neurology Foundation Announces the Launch of Infantilespasmsinfo.org
11. After a Stroke, When Seconds Count, Innovative Device from NeuroInterventions Speedily Restores Brains Blood Flow

Post Your Comments:

Neuro Kinetics Statement Concerning Newspap...( PITTSBURGH Nov. 10 /- Neuro Kinetics ...),Health